PRKN and neoplasm: Many studies reported that mitophagy-associated molecules PINK1, Parkin, BNIP3, FUNDC1 promote tumor development, and provide targets for therapeutic inhibition in multiple cancers (Tan et al., 2007; D’Amico et al., 2015; Liu et al., 2018; Hui et al., 2019).